Miniaturized Liquid Chromatography Analysis of Dietary Supplements
Researchers have evaluated three different miniaturized liquid chromatography (LC) instruments for the analysis of caffeine in dietary supplements (1).
The range of dietary supplements available to consumers has exploded in recent years, with sellers purporting a broad spectrum of properties such as anti-ageing, stimulating, fat-burning, and various other health‑related benefits, with new formulations being developed regularly. Botanical species are of particular concern because of their perceived safety to many consumers and the fact they fall under the category of food as they are derived from plants. As such, the regulations for their preparation, distribution, and labelling are not as strict as those established for pharmaceutical products. Unlike pharmaceuticals, the amount of active ingredients within these products may not be specified. One of the more prominent components in these types of products is caffeine. A potent central nervous system stimulant with many effects on the body’s metabolism and naturally present in plants such as coffee or tea, the amount of caffeine in the raw product can vary widely. The consequence of which being that even if the amount of botanical species used is specified, the accurate amount of caffeine in the final product is unknown.
There are several different risks associated with high intake of caffeine, and an increasing demand for analytical methods that can evaluate the quality, effectiveness, and safety of dietary supplements and their caffeine content. Unfortunately, many of the reported methods for the study of such supplements employ sophisticated instrumentation that may not be suitable for routine tests. Therefore, researchers aimed to develop a simple and rapid method that could facilitate better control for dietary supplements.
The study focused on three miniaturized LC instruments: a benchtop capillary LC (capLC) system, a benchtop nano LC (nanoLC) system, and a portable LC system, evaluating and comparing them for the analysis of caffeine in dietary supplements.
Commercial products derived from different sources of caffeine were analyzed and researchers found that methods based on benchtop systems were superior in terms of sensitivity; however, the portable LC-based method was superior in terms of simplicity and throughput, with a total analysis time of below 15 min. Utilizing the obtained results, researchers developed a new method for the rapid measurement of caffeine in dietary supplements by portable miniaturized LC. The method provided good linearity within the 1–20 μg/mL interval, and it allowed the quantification of caffeine even in products derived from decaffeinated green coffee extracts. The researchers believe the proposed portable LC-based method can be used as a simple and rapid alternative to estimate the quality, effectiveness, and safety of dietary supplements, with regards to their caffeine content.—L.B.
References
- C. Soto, H.D. Ponce-Rodríguez, J. Verdú-Andrés, et al., J. Chromatogr. A 1664, 462770 (2022).
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
